| 1 |
34982278 | LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer. | 2022 Jan 4 |
1 |
| 2 |
32409422 | Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures. | 2020 Aug |
1 |
| 3 |
30591146 | Lysophosphatidic acid triggers cathepsin B-mediated invasiveness of human endometriotic cells. | 2018 Nov |
1 |
| 4 |
28943105 | A549 cells as a model to study endogenous LPA1 receptor signaling and regulation. | 2017 Nov 15 |
1 |
| 5 |
23838008 | Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells. | 2013 Nov |
1 |
| 6 |
22286231 | Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity. | 2012 Feb |
2 |
| 7 |
21915944 | Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3. | 2011 Nov |
1 |
| 8 |
19420982 | Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways. | 2009 |
1 |
| 9 |
14660630 | Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. | 2004 Feb 20 |
2 |
| 10 |
15530853 | Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells. | 2004 Dec 10 |
1 |
| 11 |
14500756 | Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. | 2003 Oct |
3 |